Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, and Bladder and Urothelial Cancer Treatments.
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment?
Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Equivocal bone lesions on PSMA PET/CT: systematic review and meta-analysis on their prevalence and malignancy rate
Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement
Single‐cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer
Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years
Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram
Association Between Combined <i>TMPRSS2:ERG</i> and <i>PCA3</i> RNA Urinary Testing and Detection of Aggressive Prostate Cancer
AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer
Complications After Systematic, Random, and Image-guided Prostate Biopsy
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States
Application of anatomically accurate, patient-specific 3D printed models from MRI data in urological oncology
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy
Patterns of Repeat Prostate Biopsy in Contemporary Clinical Practice
Clinicopathologic Outcomes of Cystic Renal Cell Carcinoma
Maximal Testosterone Suppression in Prostate Cancer—Free vs Total Testosterone
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group